Newfound Research’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6
Closed 154
2019
Q3
$0 Buy
6
+1
+20% +$46 ﹤0.01% 165
2019
Q2
$0 Hold
5
﹤0.01% 168
2019
Q1
$0 Hold
5
﹤0.01% 160
2018
Q4
$0 Hold
5
﹤0.01% 144
2018
Q3
$0 Hold
5
﹤0.01% 186
2018
Q2
$0 Hold
5
﹤0.01% 171
2018
Q1
$0 Hold
5
﹤0.01% 178
2017
Q4
$0 Hold
5
﹤0.01% 191
2017
Q3
$0 Hold
5
﹤0.01% 183
2017
Q2
$0 Hold
5
﹤0.01% 180
2017
Q1
$0 Hold
5
﹤0.01% 178
2016
Q4
$0 Hold
5
﹤0.01% 141
2016
Q3
$0 Hold
5
﹤0.01% 148
2016
Q2
$0 Buy
+5
New +$399 ﹤0.01% 142

Other funds holding CAH

Newfound Research's CAH Position: Q4 2019 in Review

Newfound Research sold out of Cardinal Health (CAH) in Q4 2019, closing a stake of 6 shares.

Newfound Research first reported a position in CAH in Q2 2016 and held it in 14 quarters. The position peaked at $0 in Q3 2019. 713 funds tracked by Wall St. Rank hold CAH as of Q4 2019.

  • Newfound Research reported no remaining Cardinal Health position as of Q4 2019 after selling out during the quarter.
  • Newfound Research sold 6 Cardinal Health shares in Q4 2019.
  • Newfound Research first reported a position in Cardinal Health in Q2 2016 and held it in 14 quarters.
  • Newfound Research's Cardinal Health position peaked at $0 in Q3 2019.
  • 713 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2019.

Based on Newfound Research's 13F filing for Q4 2019, filed 10 Feb 2020.